Biotech Bull Market Intact Despite Shaky Start

Biotech stocks got roughed up in the first quarter of 2018 with unusual volatility and peak prices on March 12, driven down not so much on Company or pricing policy news but rather entanglement with the tech turmoil of large cap Nasdaq stocks.